Orange Book product · Generic (ANDA)
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
At a glance
May 29, 2001
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 29, 2001
25 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
Strength
EQ 0.05% BASE;1%
Dosage form
CREAM
Route
TOPICAL
TE code
AB
Application
ANDA 075673
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
- 2000LOTRISONEBrand (NDA)
NDA 020010 · MERCK SHARP DOHME
- 1984LOTRISONEBrand (NDA)
NDA 018827 · ORGANON
- 2015CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 202894 · GLENMARK SPECLT
- 2005CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 076516 · FOUGERA PHARMS
- 2004CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 076493 · SUN PHARMA CANADA
- 2002CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 076002 · ACTAVIS MID ATLANTIC
- 2001CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 075502 · FOUGERA PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
